Area under the curve (AUC)
Showing 1 - 25 of >10,000
Patients Receiving MMF for Diffuse Cutaneous or Pulmonary
Recruiting
- Systemic Sclerosis
- AUC of MPA measure
-
Paris, FranceCochin hospital, AP-HP
Nov 19, 2021
Tumors, NSCLC Trial (Epacadostat 25 mg, Epacadostat 100 mg, pembrolizumab 200 mg)
Completed
- Neoplasms
- Carcinoma, Non-Small-Cell Lung
- Epacadostat 25 mg
- +7 more
- (no location specified)
Aug 17, 2022
Vancomycin, Adult, Area Under Curve Trial in Greenfield Park (Vancomycin dose adjustment using the Bayesian method, Vancomycin
Completed
- Vancomycin
- +2 more
- Vancomycin dose adjustment using the Bayesian method
- Vancomycin dose adjustment using the trough level method
-
Greenfield Park, Quebec, CanadaCharles-Le Moyne Hospital
Sep 9, 2021
Parkinson Disease Trial in Warsaw (Fecal Microbiota Transfer)
Enrolling by invitation
- Parkinson Disease
- Fecal Microbiota Transfer
-
Warsaw, PolandDepartment of Neurology, Faculty of health sciences, Medical Uni
Jan 10, 2022
Informed preciSion doSIng tO iNdividualise and Optimize
Not yet recruiting
- Pharmacokinetics
- +4 more
- venipuncture
- (no location specified)
Oct 16, 2023
COPD Trial (Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg, Fluticasone Furoate / Vilanterol
Withdrawn
- COPD
- Beclometasone Dipropionate / Formoterol Fumarate / Glycopyrronium 100/6/10 mcg
- Fluticasone Furoate / Vilanterol Trifenatate 100/25 mcg
- (no location specified)
Jan 19, 2022
ICU Predictive Score of WEaning Success in Patients At Risk of
Recruiting
- Mechanical Ventilator Weaning
- +12 more
-
Clermont-Ferrand, FranceCHU
Jan 30, 2023
Irritable Bowel Syndrome Trial in Nottingham (Psyllium, Methylcellulose, Maltodextrin)
Recruiting
- Irritable Bowel Syndrome
- Psyllium
- +2 more
-
Nottingham, Nottinghamshire, United KingdomUniversity Hospital Clinical Research Centre
Jun 9, 2023
Advanced Malignant Tumor Trial in Chengdu (QLF31907)
Recruiting
- Advanced Malignant Neoplasm
-
Chengdu, Sichuan, ChinaSichuan Cancer Hospital
Dec 8, 2021
Optimizing Vancomycin Therapy in Children
Recruiting
- Sepsis
- +3 more
-
Philadelphia, PennsylvaniaChildren's Hospital of Philadelphia
Jan 17, 2023
LSCI and Thermography in Diabetic Foot Patients Affected by
Not yet recruiting
- Diabetes Mellitus, Type 2
- +2 more
- (no location specified)
Mar 30, 2023
Severe Hemophilia A Trial in Iran, Islamic Republic of (Factor VIII, recombinant human with Fc fusion (rFVIII-Fc))
Completed
- Severe Hemophilia A
- Factor VIII, recombinant human with Fc fusion (rFVIII-Fc)
-
Isfahan, Iran, Islamic Republic of
- +4 more
Nov 13, 2023
17-OHPC in Pregnancy: IM vs SC Routes
Recruiting
- Preterm Birth
- 17-Hydroxyprogesterone Caproate 250 mg IM Dose
- 17-Hydroxyprogesterone Caproate 275 mg SC Dose
-
Newark, Delaware
- +3 more
Feb 2, 2022
A Novel Nomogram to Predict Postoperative Overall Survival in
Completed
- Gastrointestinal Cancers - Stomach
- +4 more
- observation
-
Nanjing, Jiangsu, ChinaJinling Hospital
Nov 25, 2022
Acute Myeloid Leukemia Trial in Canada, Spain, United States (Decitabine and Cedazuridine (ASTX727), Venetoclax)
Recruiting
- Acute Myeloid Leukemia
- Decitabine and Cedazuridine (ASTX727)
- Venetoclax
-
Los Angeles, California
- +15 more
Jul 29, 2022
Multitask Deep Learning System at Spine Metastasis CT
Not yet recruiting
- To Evaluate the Spinal Instability Detection Performance of the DLS
- Deep Learning System
- (no location specified)
May 31, 2022
Advanced/Metastatic NSCLC Trial in Worldwide (Ixabepilone, 32 mg/m^2, Paclitaxel, 200 mg/m^2, Carboplatin (area under the
Completed
- Advanced/Metastatic Non-Small Cell Lung Cancer
- Ixabepilone, 32 mg/m^2
- +2 more
-
La Jolla, California
- +32 more
Oct 6, 2020
Healthy Trial in Saint-Herblain (5-MTHF glucosamine salt, 5-MTHF calcium salt 1, 5-MTHF calcium salt 2)
Recruiting
- Healthy
- 5-MTHF glucosamine salt
- +2 more
-
Saint-Herblain, FranceBiofortis
Jan 31, 2023
End-Stage Renal Disease, End-Stage Kidney Disease, Kidney Failure, Chronic Trial in Edgewater, Tampa (MK-2060, Placebo)
Recruiting
- End-Stage Renal Disease
- +2 more
- MK-2060
- Placebo
-
Edgewater, Florida
- +1 more
Jan 30, 2023
Prediction of Radiation-induced Late Intestinal Injury
Not yet recruiting
- Radiation-induced Intestinal Injury
- NCRT+TME
- (no location specified)
Feb 19, 2023
Respiratory Syncytial Viruses Trial in London (MK-1654, Placebo, RSV-A Memphis 37b)
Completed
- Respiratory Syncytial Viruses
- Clesrovimab
- +2 more
-
London, United KingdomHVIVO Services Ltd ( Site 0001)
Aug 29, 2022
Chronicization of Radiation-induced Acute Intestinal Injury
Not yet recruiting
- Radiation-induced Intestinal Injury
- NCRT+TME
- (no location specified)
Feb 19, 2023
Alzheimer's Disease Trial in Changsha (AD16 5mg?10mg?20mg?30mg?40mg?60mg?80mg, AD16 5mg?10mg?20mg?30mg?40mg?60mg?80mg)
Completed
- Alzheimer's Disease
- AD16 5mg、10mg、20mg、30mg、40mg、60mg、80mg
- AD16 placebo 5mg、10mg、20mg、30mg、40mg、60mg、80mg
-
Changsha, ChinaThe Central South University Xiang Ya Hospital
Mar 14, 2023